Solazyme (SZYM) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Solazyme (SZYM) Expects H215 Revenue Acceleration on Product Line Expansion, New Product Introductions - Cowen
May 7, 2015 12:27 PM EDTCowen and Company maintains its Market Perform rating on Solazyme, Inc. (Nasdaq: SZYM) and moves its price target from $3 up to $4 following the company's Q1 announcement on Wednesday night.
Analyst Jeffrey Osborne noted that the firm was expecting Solazyme to report Q1 loss of $0.34 per share on revenue of $15.3 million, while the company actually reported Q1 loss of $0.37 per share and revenue of $12.6 million.
Osborne noted management... More
